Novel Angiogenic Factors for Predicting Preeclampsia: sFlt-1, PlGF, and Soluble Endoglin~!2008-08-29~!2008-12-15~!2009-01-02~!
The Open Clinical Chemistry Journal · 2009
DOI: 10.2174/1874241600902010001 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Open Clinical Chemistry Journal, 2009. Verfasst von Yu Chen. Die Arbeit wurde bisher 16-mal zitiert (Crossref).
Abstract (Originalsprache)
Preeclampsia is a devastating multisystem syndrome and is a major cause of maternal, fetal and neonatal morbidity and mortality.Angiogenic factors contribute to the molecular mechanisms of preeclampsia and its main phenotypes such as hypertension and proteinuria.Very recently, novel anti-angiogenic proteins including soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin (sEng), and one pro-angiogenic protein placental growth factor (PlGF) have been found to be significantly abnormal several weeks preceding the onset of clinical signs and symptoms.Automatic immunoassays are being developed for sFlt-1 and PlGF.This article will summarize our current knowledge of these markers and their roles on predicting preeclampsia.
Zitieren
APA
Chen, Y. (2009). Novel Angiogenic Factors for Predicting Preeclampsia: sFlt-1, PlGF, and Soluble Endoglin~!2008-08-29~!2008-12-15~!2009-01-02~!. The Open Clinical Chemistry Journal. https://doi.org/10.2174/1874241600902010001
Vancouver
Chen Y. Novel Angiogenic Factors for Predicting Preeclampsia: sFlt-1, PlGF, and Soluble Endoglin~!2008-08-29~!2008-12-15~!2009-01-02~!. The Open Clinical Chemistry Journal. 2009. doi:10.2174/1874241600902010001
BibTeX
@article{Chen2009,
author = {Chen, Yu},
title = {Novel Angiogenic Factors for Predicting Preeclampsia: sFlt-1, PlGF, and Soluble Endoglin~!2008-08-29~!2008-12-15~!2009-01-02~!},
journal = {The Open Clinical Chemistry Journal},
year = {2009},
doi = {10.2174/1874241600902010001}
}
EUVIMED